Literature DB >> 32780175

The prevalence of and factors associated with depressive symptoms in the Korean adults: the 2014 and 2016 Korea National Health and Nutrition Examination Survey.

Jae Won Hong1, Jung Hyun Noh1, Dong-Jun Kim2.   

Abstract

PURPOSE: This study was performed to investigate the prevalence of and factors associated with depressive symptoms in the Korean adult population.
METHODS: 10,710 participants in the 2014 and 2016 Korea National Health and Nutrition Examination Survey (KNHANES) were analyzed in this study. Assessment of depressive symptoms was performed using the self-administered nine-item Patient Health Questionnaire (PHQ-9).
RESULTS: The weighted prevalence of clinically relevant depression (PHQ-9 score ≥ 10) in the Korean adult population was 6.1% [5.5-6.8%]. Female sex, adults aged 19-29 years, elementary school graduation, living alone were significantly associated with clinically relevant depression. Having a household income ≤ 24th percentile was associated with a 2.26 (CI 1.49-3.45, p < 0.001)-fold higher prevalence of clinically relevant depression compared to having a household income ≥ 75th percentile. Regarding occupation, treating managers and professionals as controls, we found that unemployed individuals (OR 2.36, 95% CI 1.52-3.65, p < 0.001) had an increased risk of clinically relevant depression. Alcohol consumption < 30 g/day was reversely associated with clinically relevant depression (OR 0.75, 95% CI 0.62-0.93, p = 0.007), when abstain from alcohol was treated as control. Current smokers (OR 3.42, 95% CI 2.54-4.60, p < 0.001) and ex-smokers (OR 1.73, 95% CI 1.24-2.42, p = 0.001) had a higher risk of clinically relevant depression than never-smokers.
CONCLUSIONS: The estimated prevalence of depressive symptoms in a representative sample of the Korean adult population was 6.1%. This study suggests that younger age, female sex, elementary school graduation, living alone, low household income, current smoking, and being unemployed are associated with depressive symptoms.

Entities:  

Keywords:  Depression; Korea National Health and Nutrition Examination Survey (KNHANES); Patient Health Questionnaire (PHQ9); Prevalence; Risk factor

Mesh:

Year:  2020        PMID: 32780175     DOI: 10.1007/s00127-020-01945-2

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  44 in total

1.  Lifetime and 12-month prevalence of DSM-IV psychiatric disorders among Korean adults.

Authors:  Maeng Je Cho; Jang-Kyu Kim; Hong Jin Jeon; Tongwoo Suh; In-Won Chung; Jin Pyo Hong; Jae-Nam Bae; Dong-Woo Lee; Jong-Ik Park; Seong-Jin Cho; Choong-Koung Lee; Bong-Jin Hahm
Journal:  J Nerv Ment Dis       Date:  2007-03       Impact factor: 2.254

2.  Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul.

Authors:  C K Lee; Y S Kwak; J Yamamoto; H Rhee; Y S Kim; J H Han; J O Choi; Y H Lee
Journal:  J Nerv Ment Dis       Date:  1990-04       Impact factor: 2.254

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 4.  A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression.

Authors:  Laura Manea; Simon Gilbody; Dean McMillan
Journal:  Gen Hosp Psychiatry       Date:  2014-09-23       Impact factor: 3.238

5.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

6.  Cross-national difference in the prevalence of depression caused by the diagnostic threshold.

Authors:  Sung Man Chang; Bong-Jin Hahm; Jun-Young Lee; Min Sup Shin; Hong Jin Jeon; Jin-Pyo Hong; Hochang B Lee; Dong-Woo Lee; Maeng Je Cho
Journal:  J Affect Disord       Date:  2007-08-28       Impact factor: 4.839

7.  Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study.

Authors:  Changsu Han; Sangmee Ahn Jo; Ji-Hyun Kwak; Chi-Un Pae; David Steffens; Inho Jo; Moon Ho Park
Journal:  Compr Psychiatry       Date:  2007-10-24       Impact factor: 3.735

8.  The prevalence of suicidal ideation and depression among primary care patients and current management in South Korea.

Authors:  Yoon-Joo Choi; Weon-Young Lee
Journal:  Int J Ment Health Syst       Date:  2017-02-07

9.  The Psychometric Properties of the Patient Health Questionnaire-9 in a Sample of Korean University Students.

Authors:  Yang Eun Kim; Boram Lee
Journal:  Psychiatry Investig       Date:  2019-12-25       Impact factor: 2.505

10.  The prevalence and factors associated with hearing impairment in the Korean adults: the 2010-2012 Korea National Health and Nutrition Examination Survey (observational study).

Authors:  Jae W Hong; Ju H Jeon; Cheol R Ku; Jung H Noh; Hyung J Yoo; Dong-Jun Kim
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

View more
  3 in total

1.  Association between sugar-sweetened beverage consumption and depression and suicidal ideation among Korean adults: a cross-sectional study from the 2014 and 2016 Korean National Health and Nutrition Examination Survey (KNHANES).

Authors:  Jiyeong Kim; Changbin Hong; Gyeongsil Lee
Journal:  Nutr Res Pract       Date:  2021-09-09       Impact factor: 1.926

2.  The Prevalence of Depression Symptoms and Their Socioeconomic and Health Predictors in a Local Community with a High Deprivation: A Cross-Sectional Studies.

Authors:  Maciej Polak; Grzegorz Józef Nowicki; Katarzyna Naylor; Robert Piekarski; Barbara Ślusarska
Journal:  Int J Environ Res Public Health       Date:  2022-09-19       Impact factor: 4.614

3.  Depression, anxiety, and stress in Korean general population during the COVID-19 pandemic.

Authors:  Hooyeon Lee; Dongwoo Choi; Jung Jae Lee
Journal:  Epidemiol Health       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.